Search result for 'semaglutide'

OneSource Specialty Pharma's Unit 2 in Bengaluru receives GMP certification from ANVISA, enabling the company to supply pharmaceutical products, including GLP-1s, to the Brazilian market.

Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement in the US over a patent infringement lawsuit regarding generic Ozempic, a drug used for blood sugar and weight loss.

Biocon and Biomm SA have partnered to commercialize Biocon's diabetes drug Semaglutide (gOzempic) in Brazil, addressing the country's high diabetes incidence.